Funds and ETFs FDC Limited

Equities

FDC

INE258B01022

Pharmaceuticals

Delayed Bombay S.E. 03:00:39 2024-05-18 EDT 5-day change 1st Jan Change
482.6 INR 0.00% Intraday chart for FDC Limited +9.67% +21.85%

ETFs positioned on FDC Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 112 M€ +5.41% -
FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations, and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. FDC Stock
  4. Funds and ETFs FDC Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW